A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...

Discover why pancreatic cancer's warning signs often go unnoticed, masquerading as everyday health issues, learn the crucial red flags that shouldn't be ignored ...

Researchers have developed a simple blood test to detect pancreatic cancer before it spreads to other sites in the body. The ...

Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.